Parkinson’s Disease Funding Analyzer Launched on Journal of Parkinson’s Disease Website

31 March 2016

The Journal of Parkinson’s Disease (JPD) is proud to announce the launch of the Parkinson’s Disease Funding Analyzer (PDFA) on the JPD website. It is a free service that is part of a new suite of online features that have been designed to serve the needs of the Parkinson’s disease (PD) research community.

PDFA presents in-depth data on 114 funders from 40 countries including all of the European Union, Australia, Canada, Ireland, Qatar, the United Kingdom, and the United States.

"This is a unique and remarkable tool that will be very valuable to everyone doing Parkinson's research," explained JPD's Editor-in-Chief Patrik Brundin, MD, PhD, Van Andel Research Institute. "It is becoming increasingly important to know more about the funding landscape and about who is working on what project so effective collaborations can be sought out."

Working with development partner ÜberResearch, a solutions and services company focused on the specific needs of science funders, PDFA includes all funding related to PD drawn from ÜberResearch’s extensive grant database of more than $940 billion of funded research, representing more than 2 million projects from 200 funders like the National Institutes of Health and the National Science Foundation in the U.S. and the Wellcome Trust and U.K. Research Councils in the U.K.

PDFA allows users to easily locate funding related to PD and analyze funding streams and trends. Further, it facilitates a better understanding of research organizations’ funding portfolios and the funding patterns of specific funders, both of which are critical when developing grant applications. For example, users can conduct line-of-investigation queries (e.g., alpha-synuclein, L-Dopa, transplantation) to look for funding trends and to see which investigators in which countries have been the most successful in obtaining funding in a given area of PD research. New funding information will be added to the PDFA on an ongoing basis.

”We invite all PD researchers to register at www.journalofparkinsonsdisease.com/funding for this valuable service, which we are pleased to make available at no charge,” added Dr. Brundin. Registration not only enbles users to access the PDFA, but also use other features on the site. 

#  #  #

NOTES FOR EDITORS

ABOUT THE JOURNAL OF PARKINSON’S DISEASE (JPD)

Launched in 2011 the Journal of Parkinson’s Disease is dedicated to providing an open forum for original research in basic science, translational research and clinical medicine that will expedite our fundamental understanding and improve treatment of Parkinson’s disease. The journal is international and multidisciplinary and aims to promote progress in the epidemiology, etiology, genetics, molecular correlates, pathogenesis, pharmacology, psychology, diagnosis and treatment of Parkinson’s disease. It publishes research reports, reviews, short communications, and letters-to-the-editor and offers very rapid publication and an affordable open access option. 

ABOUT IOS PRESS

Commencing its publishing activities in 1987, IOS Press is headquartered in Amsterdam with satellite offices in the USA, Germany, India and China and serves the information needs of scientific and medical communities worldwide. IOS Press now publishes over 100 international journals and about 75 book titles each year on subjects ranging from computer sciences and mathematics to medicine and the natural sciences.

Contact:
Daphne Watrin
IOS Press
Tel: +31 20 688 3355
Fax: +31 20 687 0019
Email: d.watrin@iospress.nl